HETEROBICYCLOARYL RORC2 INHIBITORS AND METHODS OF USE THEREOF

The present invention provides compounds, pharmaceutical compositions, methods of inhibiting RORy activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such compounds and pharmaceutical compositions.

Saved in:
Bibliographic Details
Main Authors JONES, PETER, THORARENSEN, ATLI, WENNERSTÅL, GÖRAN MATTIAS, ZAPF, CHRISTOPH WOLFGANG, MEYERS, MARVIN JAY, MENTE, SCOT RICHARD, SCHNUTE, MARK EDWARD, BLINN, JAMES ROBERT, FLICK, ANDREW CHRISTOPHER, XING, LI, KURUMBAIL, RAVI G, ZAMARATSKI, EDOUARD, KAILA, NEELU, KIEFER, JAMES RICHARD JR
Format Patent
LanguageEnglish
Serbian
Published 30.11.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides compounds, pharmaceutical compositions, methods of inhibiting RORy activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such compounds and pharmaceutical compositions.
Bibliography:Application Number: RS2018P001058